Acorda Therapeutics' Unattributed VC - IV Round

Acorda Therapeutics raised a round of funding on March 15, 2004.

Acorda Therapeutics, a privately held biotechnology company, is developing therapies for spinal cord injury (SCI and related neurological conditions, including multiple sclerosis (MS. The CompanyĆ’-s …

Articles about Acorda Therapeutics' Unattributed VC - IV Round: